Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision: v3.4.3 replacing v3.4.2. This appears to be a system/UI update with no changes to the study details presented on the page.SummaryDifference0.1%

- Check53 days agoChange DetectedAdded Revision: v3.4.2 and removal of the general government funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check60 days agoChange DetectedA government funding lapse notice banner was added. The site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check67 days agoChange DetectedThe page updated with a new 'Show glossary' option, capitalization adjustments for QC labels ('Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a revision bump to v3.4.0.SummaryDifference0.2%

- Check82 days agoChange DetectedThe site revision label in the footer was updated from Revision: v3.3.3 to Revision: v3.3.4.SummaryDifference0.1%

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.